Stock Analiz

Eledon Pharmaceuticals, Inc. (ELDN) stock forecast and price target

Price $2.12 · data as of November 13, 2026

12-month price target

Average target$9.00
Upside / downside+325.5%
Analysts5
ConsensusStrong buy
Low $7.00Average $9.00High $12.00

Gold marker: average target · white marker: today’s price ($2.12)

Analyst ratings

Strong buy 0Buy 6Hold 0Sell 0Strong sell 0

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$-0.89−71.2%$0
Next fiscal year
ends December 31, 2027
$-0.76+14.2%$0
Next quarter
ends December 31, 2026
$-0.15−55.0%$0
Quarter after
ends March 31, 2027
$-0.20+39.4%$0

Consensus of the analysts covering Eledon Pharmaceuticals, updated daily. In the last 30 days 0 estimates were raised and 2 lowered.

Frequently asked questions

What is the Eledon Pharmaceuticals stock price target?

The average 12-month target from 5 analysts is $9.00, 325.5% above the current price of $2.12 Targets range from $7.00 to $12.00.

Is Eledon Pharmaceuticals a buy according to analysts?

The consensus rating is “Strong buy” (6 buy). Ratings are opinions, not guarantees; this is not investment advice.

How much is Eledon Pharmaceuticals expected to earn?

Analysts expect EPS of $-0.89 for the fiscal year ending December 31, 2026 and $-0.76 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.